B&A Therapeutics Report issue

For profit Phase 2
Founded: Marseilles France (2014)
Status: No NME R&D (2014)

Organization Overview

First Clinical Trial
2019
NCT03899324
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

B&A Therapeutics